Zdrowie i gospodarka · 26/03/2009
FDA's CBER Invites Blood Establishments to Pilot eSubmitter Program for Source Plasma
The FDA's Center for Biologics Evaluation and Research is launching a pilot program to evaluate its eSubmitter system for submitting biologics license applications and supplements for blood and blood components, and is inviting blood establishments that collect Source Plasma to participate